cuid,created_at,provider,model,temperature,input_tokens,output_tokens,reason
d4e5e473-2d2f-4a6b-96de-2617e04e271b,2025-03-27 19:48:53.218905+00:00,qwen,qwen2-72b-instruct,0,4464,323,"I prioritize policies that ensure safety, ethical oversight, and non-profit motives while allowing for necessary medical advancements and community involvement."
d2b24063-3c61-49e4-9599-3466a1342e55,2025-03-27 19:49:02.827657+00:00,qwen,qwen2-72b-instruct,0,4467,324,"I favor moderate policies allowing non-heritable editing for clinical use with oversight, leaning towards permitting mitochondrial donation under strict conditions."
730a4acc-fab2-48f3-8c5f-493a662c2dfb,2025-03-27 19:49:12.400797+00:00,qwen,qwen2-72b-instruct,0,4467,329,"I prioritize policies that focus on non-heritable edits, safety, ethics, and non-profit motives while restricting heritable edits and ensuring community oversight."
b34b5db0-d68e-4ff4-8bbd-0d848bd80bcc,2025-03-27 19:49:22.303806+00:00,qwen,qwen2-72b-instruct,0,4467,330,"I prioritize policies that focus on clinical use with oversight, limit heritable changes, and restrict for-profit motives while allowing non-heritable editing and research."
d8b1ee42-93bc-4015-9a66-55ee0f0dfdd3,2025-03-27 19:49:32.107740+00:00,qwen,qwen2-72b-instruct,0,4467,328,"I prioritize clinical use with oversight, support non-heritable editing, and mitochondrial donation, while being cautious about commercialization and heritable edits."
0d18af18-1744-4cc6-a4b3-8fe321473711,2025-03-27 19:49:41.729022+00:00,qwen,qwen2-72b-instruct,0,4467,322,"I prioritize policies that ensure safety, ethical standards, and non-profit motives while allowing necessary medical advancements and community oversight."
f6cd0f2c-79ad-4445-8402-5cd0ef4ae22e,2025-03-27 19:49:51.295054+00:00,qwen,qwen2-72b-instruct,0,4467,330,"I favor non-heritable edits and mitochondrial donation under strict oversight, opposing commercialization and heritable edits due to ethical concerns and unknown long-term effects."
1cb61983-0fba-47ed-b357-f60227a30b58,2025-03-27 19:50:01.172361+00:00,qwen,qwen2-72b-instruct,0,4467,321,"Prefer policies that balance scientific progress with ethical considerations, ensuring accessibility and prohibiting profit-driven motives in genome editing."
84e6c1ea-0372-452a-8225-1f1b916b029b,2025-03-27 19:50:10.802986+00:00,qwen,qwen2-72b-instruct,0,4467,322,"I favor non-heritable edits and strong oversight, leaning towards therapeutic uses while minimizing risks and ensuring equitable access."
b6ae4906-09ba-4515-b32a-58ebe6297622,2025-03-27 19:50:20.536681+00:00,qwen,qwen2-72b-instruct,0,4467,328,"Prefer cautious approaches with strict oversight, leaning towards non-heritable edits and against commercialization, with a strong emphasis on safety and ethics."
3e9e2adf-b36d-42e5-8514-c6df1c0249a2,2025-03-27 19:50:30.216831+00:00,qwen,qwen2-72b-instruct,0,4467,324,"I favor cautious, regulated use of genome editing for medical purposes while prohibiting enhancements and for-profit exploitation, aiming for equitable access."
c77fd47b-c25f-4fe0-9627-c2ddf40c03bb,2025-03-27 19:50:39.908158+00:00,qwen,qwen2-72b-instruct,0,4464,329,"Prefer options allowing non-heritable editing and mitochondrial donation under strict oversight, oppose unrestricted editing, and lean towards cautious but not prohibitive policies."
9ffb6453-9075-4872-96b5-acf81804d681,2025-03-27 19:50:49.907383+00:00,qwen,qwen2-72b-instruct,0,4462,326,"I prioritize safety, ethics, and non-profit motives while limiting inheritable edits due to concerns over inequality and unforeseen long-term effects."
b3f839a2-7d45-4a44-8e56-d21004010349,2025-03-27 19:50:59.865544+00:00,qwen,qwen2-72b-instruct,0,4467,330,"I prioritize policies that focus on clinical use with oversight, followed by non-heritable editing, mitochondrial donation, research, prohibition, and unrestricted use last."
404140dc-84e3-480f-a92b-3c63fc6af9ec,2025-03-27 19:51:09.693969+00:00,qwen,qwen2-72b-instruct,0,4467,325,"I favor oversight and non-profit motives, support non-heritable editing, and am cautious about heritable changes and unrestricted use."
8ded561e-fa11-4eeb-8438-0128892c00ed,2025-03-27 19:51:19.423559+00:00,qwen,qwen2-72b-instruct,0,4465,327,"I favor cautious, non-profit, and non-heritable genome editing for medical treatments with strict oversight, opposing unrestricted or profit-driven applications."
695e9959-9723-4b20-989a-f46b97104fb5,2025-03-27 19:51:29.147120+00:00,qwen,qwen2-72b-instruct,0,4467,322,"I prioritize policies that focus on clinical use, safety, and ethical oversight while limiting heritable edits and commercial exploitation."
a497647c-71f7-4082-8d57-8f1e5a588ba2,2025-03-27 19:51:38.786958+00:00,qwen,qwen2-72b-instruct,0,4464,322,"Prefer options allowing non-heritable editing and mitochondrial donation under strict oversight, oppose unrestricted editing and complete prohibition."
20216b66-fe16-48fc-b626-518a68a0951f,2025-03-27 19:51:48.300950+00:00,qwen,qwen2-72b-instruct,0,4467,330,"Precautionary approach favored, supporting non-heritable editing for treatment under strict oversight, with concerns over commodification and slippery slope to unethical practices."
94ed4eac-d935-4805-b805-f23a403dfbb3,2025-03-27 19:51:58.205329+00:00,qwen,qwen2-72b-instruct,0,4467,326,"Prefer options allowing non-heritable editing with oversight, against unrestricted editing, and completely banning seems too restrictive given potential medical benefits."
63d2d7c9-5413-4830-a1d1-0518716d0f02,2025-03-27 21:07:07.958029+00:00,qwen,qwen2-72b-instruct,0,4467,327,"I prioritize policies that focus on non-heritable edits, strong oversight, and ethical standards while allowing necessary medical advancements and excluding profit motives."
04794007-920d-4ef4-9d54-189c0b2799ff,2025-03-27 21:07:17.965528+00:00,qwen,qwen2-72b-instruct,0,4467,327,"I prioritize policies that focus on non-heritable editing with oversight, permit mitochondrial donation, and restrict for-profit motives while allowing essential research."
69651038-43f8-48f9-a04e-cbd636a03800,2025-03-27 21:07:28.002279+00:00,qwen,qwen2-72b-instruct,0,4467,328,"I favor cautious, regulated use of genome editing for clinical purposes with oversight, leaning towards non-heritable edits, and strongly against unrestricted use."
8dc3927f-0c3a-4f79-be7b-f734779f7395,2025-03-27 21:07:38.169064+00:00,qwen,qwen2-72b-instruct,0,4467,325,"I favor controlled use with oversight, leaning towards non-heritable edits for now due to ethical concerns and unknown long-term impacts."
fa116ee4-16cf-4c73-8769-999f80da3083,2025-03-27 21:07:48.202720+00:00,qwen,qwen2-72b-instruct,0,4467,323,"I favor cautious, regulated use for clinical treatments and research, opposing commercialization and heritable edits except under strict oversight."
e333bc53-3e08-4508-8a30-8357832d4de7,2025-03-27 21:07:58.242994+00:00,qwen,qwen2-72b-instruct,0,4465,321,"I prioritize policies that ensure safety, ethical oversight, and non-profit motives while allowing necessary medical advancements and research."
5b7298ba-9509-4e1f-a95c-91e379110ddd,2025-03-27 21:08:08.214453+00:00,qwen,qwen2-72b-instruct,0,4467,330,"Prefer options allowing non-heritable editing for treatment under strict oversight, cautious about heritable changes, oppose commercialization, and fully prohibitive policies."
5cceb4f4-4684-45a4-bd04-9435196656f3,2025-03-27 21:08:18.489950+00:00,qwen,qwen2-72b-instruct,0,4465,328,"I prioritize policies that focus on clinical use with oversight, limit inheritable changes, and restrict for-profit motives while allowing non-heritable editing."
e027d785-1449-4c43-ab9a-12f696dc03ad,2025-03-27 21:08:28.507955+00:00,qwen,qwen2-72b-instruct,0,4467,324,"I prioritize policies that focus on non-heritable editing with strict oversight, supporting medical advancements while minimizing risks and ethical concerns."
60c03bf1-c5a6-4069-9c22-941401e3a525,2025-03-27 21:08:38.549067+00:00,qwen,qwen2-72b-instruct,0,4467,325,"I favor cautious, regulated use of genome editing for medical purposes while opposing unrestricted or commercial exploitation, aiming for equitable access and safety."
5ccbb348-6ed1-4990-aa09-1f9b789c9289,2025-03-27 21:08:48.495663+00:00,qwen,qwen2-72b-instruct,0,4467,332,"I prioritize policies that focus on non-heritable edits, strong oversight, and ethical standards while limiting profit-driven motives and prohibiting heritable edits except under strict regulations."
21033e13-01ea-487d-80a9-cffcc4857a12,2025-03-27 21:08:58.798251+00:00,qwen,qwen2-72b-instruct,0,4467,328,"I prioritize policies that focus on clinical use with oversight, non-heritable editing, and prohibit for-profit motives while ensuring ethical standards and safety."
85b0733f-b1b0-4cbf-926b-e1d933b3d762,2025-03-27 21:09:08.882756+00:00,qwen,qwen2-72b-instruct,0,4467,326,"I prioritize policies that focus on non-heritable edits, strong oversight, and exclude profit motives, while opposing unrestricted or complete bans."
b0aa2fe7-5964-400e-8b73-48d146dff8d7,2025-03-27 21:09:19.012808+00:00,qwen,qwen2-72b-instruct,0,4467,325,"I favor non-heritable edits with oversight, supporting medical advancements while minimizing risks and ethical concerns, disapproving unrestricted editing."
b0b8d29e-4b95-4982-aa03-c27959799249,2025-03-27 21:09:29.032829+00:00,qwen,qwen2-72b-instruct,0,4467,322,"I prioritize policies that focus on clinical applications with oversight, followed by research, and oppose commercialization and unrestricted editing."
395bc8cb-753e-448b-b0b5-1791b8b2a87d,2025-03-27 21:09:39.089141+00:00,qwen,qwen2-72b-instruct,0,4467,321,"I prioritize policies with strict oversight, ethical standards, and non-profit motives while opposing unrestricted editing and total prohibition."
77531052-fbf8-459e-b3c3-5f2b46e1352a,2025-03-27 21:09:48.923648+00:00,qwen,qwen2-72b-instruct,0,4467,323,"I prioritize policies that ensure safety, ethical oversight, and non-profit motives while allowing for necessary medical advancements and strict regulation."
03ef180a-780c-435f-ac27-71c17ad4b8ac,2025-03-27 21:09:58.789736+00:00,qwen,qwen2-72b-instruct,0,4464,327,"I prioritize policies that focus on clinical use, safety, and ethical oversight while limiting profit motives and prohibiting inheritable changes except for serious diseases."
b2b51a24-5642-4d6a-ad00-92e7ea7b557c,2025-03-27 21:10:09.002493+00:00,qwen,qwen2-72b-instruct,0,4465,327,"I prioritize policies that focus on non-heritable edits, strong oversight, and ethical standards while limiting profit-driven motives and prohibiting reckless applications."
bce08215-45fc-4342-bbea-042a67841394,2025-03-27 21:10:18.971432+00:00,qwen,qwen2-72b-instruct,0,4467,327,"I favor controlled non-heritable editing for clinical use with oversight, less inclined towards heritable edits or unrestricted editing due to ethical concerns."
14188ed6-f243-43fd-b72c-083013ea9d2a,2025-03-27 21:10:28.859652+00:00,qwen,qwen2-72b-instruct,0,4467,324,"Prefer cautious, regulated approaches focusing on non-heritable edits and mitochondrial donation, opposing unrestricted editing and profit-driven applications."
08b17b04-74af-43e4-873e-48b24b17b827,2025-03-27 21:10:38.898031+00:00,qwen,qwen2-72b-instruct,0,4467,326,"I favor balanced regulation allowing safe, non-heritable editing for treatments with oversight, while restricting for-profit motives and prohibiting reckless enhancements."
12d92755-23ab-4752-9faf-052b75d75799,2025-03-27 21:10:48.829993+00:00,qwen,qwen2-72b-instruct,0,4465,330,"I favor non-heritable edits for treatment and research with oversight, opposing commercialization and heritable edits due to ethical concerns and unknown long-term effects."
c0cd8003-ad7c-4eed-9603-e3d3c65e89a8,2025-03-27 21:10:58.861213+00:00,qwen,qwen2-72b-instruct,0,4467,329,"I prioritize policies that focus on non-heritable edits for treatment, allow research, and mandate strict oversight, while opposing profit-driven and unrestricted editing."
2a9e79b1-d2bf-468a-8315-39c512ac8258,2025-03-27 21:11:08.894451+00:00,qwen,qwen2-72b-instruct,0,4465,328,"I favor cautious, non-heritable editing for treatment with oversight, less inclined toward unrestricted editing or complete prohibition, leaning towards non-profit motives."
